Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Celgene’s Revlimid Approved For Second-Line Multiple Myeloma

Jun 30 2006

• By Brooke McManus

Related Content

Revlimid Approved With Safeguards Against Fetal Exposure

Dec 28 2005

Third Time Is The Charm For Thalomid Myeloma Indication

May 25 2006

Revlimid Reproductive Safety Concerns Led To Broad Risk Management Plan

Apr 18 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window